Aperbio is a life sciences company committed to advancing human health through innovative diagnostic technologies. With a strong R&D team and advanced platforms in digital and real-time PCR, Aperbio develops high-performance instruments like the Pangaea PCR system, approved by CFDA and CE. Their global partnerships and ISO-certified operations drive innovation in clinical diagnostics. With multiple patented technologies and expanding international reach, Aperbio aims to bridge life science research and clinical applications, delivering precise, rapid solutions to improve healthcare worldwide.